“创新药物研发高层论坛”专家观点  

Collection of Experts' Views at Innovative Drug Research and Development Forum

作　　者：Editorial Offi ce of Progress in Pharmaceutical Sciences 

机构地区：[1]<药学进展>编辑部

出　　处：《药学进展》2015年第2期81-97,共17页Progress in Pharmaceutical Sciences

摘　　要：对2015年1月30日召开的"创新药物研发高层论坛"的专家报告内容进行归纳总结,旨在为从事药品注册、创新药及仿制药研发、药物临床试验质量管理规范(GCP)及药品非临床研究质量管理规范(GLP)工作的人士提供信息参考。A digest of expert reports presented at Innovative Drug Research and Development Forum, which was held on January 30, 2015, was introduced in this article to provide reference information for practitioners in the field of drug registration, R＆D of innovative drugs and generics, Good Clinical Practice （GCP） and Good Laboratory Practice of drug （GLP）.

关 键 词：创新药 仿制药 药品注册 GCP GLP 

分 类 号：R95[医药卫生—药学]